Metastasectomy for visceral and skeletal oligorecurrent prostate cancer-Reference-Cited by-同舟云学术

Metastasectomy for visceral and skeletal oligorecurrent prostate cancer

Published:2019-03-12 Issue:8 Volume:37 Page:1543-1549
ISSN:0724-4983
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Battaglia Antonino,Devos Gaëtan,Decaestecker Karel,Witters Manuel,Moris Lisa,Van den Broeck Thomas,Berghen Charlien,Everaerts Wouter,Albersen Maarten,Tsaturyan Arman,De Meerleer Gert,Van Poppel Hein,Goffin Karolien,Ost Piet,Tosco Lorenzo,Joniau Steven

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/content/pdf/10.1007/s00345-019-02716-8.pdf

Reference25 articles.

1. Antonarakis ES, Feng Z, Trock BJ, Humphreys EB, Carducci MA, Partin AW et al (2012) The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up. BJU Int 102:32–39

2. Yossepowitch O, Bianco FJ, Eggener SE, Eastham JA, Scher HI, Scardino PT et al (2007) The natural history of noncastrate metastatic prostate cancer after radical prostatectomy. Eur Urol 51(4):940–947 (discussion 947–948)

3. Cornford P, Bellmunt J, Bolla M, Briers E, De Santis M, Gross T et al (2017) EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer. Eur Urol 71(4):630–642

4. Decaestecker K, De Meerleer G, Lambert B, Delrue L, Fonteyne V, Claeys T et al (2014) Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence. Radiat Oncol 12(9):135

5. Grubmüller B, Baltzer P, D’andrea D, Korn S, Haug AR, Hacker M et al (2018) 68Ga-PSMA 11 ligand PET imaging in patients with biochemical recurrence after radical prostatectomy—diagnostic performance and impact on therapeutic decision-making. Eur J Nucl Med Mol Imaging 45:235–242

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From biology to the clinic — exploring liver metastasis in prostate cancer;Nature Reviews Urology;2024-04-26

2. A patient with oligometastatic hormone‐sensitive prostate cancer who achieved long‐term progression‐free survival following cytoreductive radical prostatectomy and metastasectomy;IJU Case Reports;2024-01-29

3. Solitary versus multiple bone metastases in the appendicular skeleton;BONE JOINT J;2023

4. Solitary versus multiple bone metastases in the appendicular skeleton;The Bone & Joint Journal;2023-11-01

5. Surgical Metastasectomy for Visceral and Bone Prostate Cancer Metastases: A Mini-Review;European Urology Focus;2023-03